Chinese Traditional and Herbal Drugs
|
2025, 56(23): 8597-8610
Mechanism of morroniside in ameliorating cisplatin-induced hepatotoxicity based on oxidative stress and ferroptosis pathway
Full
LIU Zhongliang1, LI Hangting2, XU Ke2, REN Xiangyu2, YANG Zuisu2, TIAN Yizhou1
Affiliations
1 Zhoushan Traditional Chinese Medicine Hospital, Zhoushan 316000, China;
2 Food and Pharmacy College, Zhejiang Ocean University, Zhoushan 316022, China
doi: 10.7501/j.issn.0253-2670.2025.23.012
Outline
Objective To investigate the protective effect and underlying molecular mechanisms of morroniside on cisplatin-induced hepatotoxicity. Methods The liver toxicity model of C57BL/6J mice was established by intraperitoneal injection of cisplatin. After four weeks of morroniside intervention treatment, the serum liver function indicators were measured. Hematoxylin-eosin (HE) stainin was used to observe liver histopathological changes; Iron accumulation in liver tissue was assessed by Prussian blue staining; Levels of inflammatory cytokine in serum were detected by ELISA; Malondialdehyde (MDA) content and activities of antioxidant enzymes in liver tissues were also determined. Western blotting and immunohistochemistry were used to detect the expressions of ferroptosis-related proteins including nuclear factor erythroid 2-related factor 2 (Nrf2), heme oxygenase-1 (HO-1) and glutathione peroxidase 4 (GPX4) in liver tissues. The AML12 cell injury model was established in vitro by cisplatin induction. Morroniside, ferroptosis inhibitor ferrostatin-1 (Fer-1), and ferroptosis inducer erastin were administered to induce cells, and the effect of morroniside on ferroptosis in AML12 cells was investigated. Cell morphology was observed; Intracellular reactive oxygen species (ROS) level was detected using DCFH-DA fluorescent probe; The changes of mitochondrial membrane potential were assessed using JC-1 staining; Cell death was evaluated using acridine orange/ethidium bromide (AO/EB) staining; Immunofluorescence staining was used to detect GPX4 and Nrf2 expressions. Results Morroniside significantly improved cisplatin-induced liver dysfunction in mice by reducing levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and total bilirubin (TBIL) in serum (P < 0.05, 0.01, 0.001), lowering levels of interleukin-1β (IL-1β), IL-6 and tumor necrosis factor-α (TNF-α) in liver tissue (P < 0.05, 0.01, 0.001), enhancing the activities of antioxidant enzymes such as glutathione peroxidase (GSH-Px), and decreasing MDA level (P < 0.05, 0.01, 0.001). Morroniside also significantly improved the disordered arrangement of hepatic cords and vacuolation of hepatic cytoplasm in mice with cisplatin-induced hepatotoxicity, restored necrosis in some cells, and reduced the massive infiltration of inflammatory cells. At the molecular level, morroniside inhibited ferroptosis by regulating GPX4 expression (P < 0.01), and attenuated oxidative stress by up-regulating Nrf2 and HO-1 expressions (P < 0.05, 0.01, 0.001), thereby inhibiting cisplatin-induced liver injury. The results of in vitro experiments were consistent with those of in vivo experiments, morroniside significantly relieved cisplatin-induced oxidative stress and ferroptosis in AML12 cells. Conclusion Morroniside alleviates cisplatin-induced hepatotoxicity by suppressing oxidative stress and ferroptosis through the regulation of the Nrf2/HO-1 axis and up-regulation of GPX4 expression.
morroniside
/
cisplatin
/
hepatotoxicity
/
ferroptosis
/
Nrf2/HO-1 axis
/
oxidative stress
刘中良, 李航婷, 许珂, 任祥雨, 杨最素, 田义洲.
基于氧化应激-铁死亡途径探讨莫诺苷改善顺铂致肝毒性的作用机制.
中草药,
2025
, 56
(23)
: 8597
-8610
.
DOI: 10.7501/j.issn.0253-2670.2025.23.012
LIU Zhongliang, LI Hangting, XU Ke, REN Xiangyu, YANG Zuisu, TIAN Yizhou.
Mechanism of morroniside in ameliorating cisplatin-induced hepatotoxicity based on oxidative stress and ferroptosis pathway[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(23)
: 8597
-8610
.
DOI: 10.7501/j.issn.0253-2670.2025.23.012
Year 2025 volume 56 Issue 23
38
0
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.23.012
- Receive Date:2025-09-06
- Online Date:2026-11-13